The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management

Author:

Sydney Guy I.1,Michalakis Konstantinos2,Nikas Ilias P.3,Spartalis Eleftherios4,Paschou Stavroula A.35

Affiliation:

1. Center for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

2. Imperial College of Medicine, London, UK

3. School of Medicine, European University Cyprus, Nicosia, Cyprus

4. 2nd Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Athens, Greece

5. School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Abstract

AbstractThis review aims to explore, present, and discuss disorders of glucose metabolism implicated in pituitary gland diseases, the appropriate interventions, as well as the therapeutic challenges that may arise. Pituitary pathologies may dysregulate glucose homeostasis, as both the excess and deficiency of various pituitary hormones can affect glucose metabolism. Increased circulating levels of growth hormone, glucocorticoids or prolactin have been shown to mainly provoke hyperglycemic states, while hypopituitarism can be associated with both hyperglycemia and hypoglycemia. Addressing the primary cause of these disorders with the use of surgery, medical treatment or radiotherapy forms the cornerstone of current management strategies. Physicians should bear in mind that some such medications have an unfavorable effect on glucose metabolism too. When unsuccessful, or until the appropriate treatment of the underlying pituitary problem, the addition of established antidiabetic therapies might prove useful. Further studies aiming to discover more accurate and effective drug preparations in combination with optimal lifestyle management models will contribute to achieving a more successful glycemic control in these patients.

Publisher

Georg Thieme Verlag KG

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism

Reference89 articles.

1. Glucose and fat metabolism in acromegaly: from mice models to patient care;J Dal;Neuroendocrinology,2016

2. Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo;G Schernthaner;Diabetologia,1985

3. Insulin resistance and androgen levels in eugonadic and hypogonadic women with prolactinoma;B A Dogan;Minerva Endocrinol,2016

4. Body composition and cardiovascular risk markers after remission of Cushing’s Disease: A prospective study using whole-body MRI;E B Geer;J Clin Endocrinol Metab,2012

5. Management of diabetes mellitus in cushing’s syndrome;A Munir;Neuroendocrinology,2010

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Metabolic Syndrome Components in Patients with Pituitary Adenoma;Hormone and Metabolic Research;2023-12-11

2. Ectopic lipid metabolism in anterior pituitary dysfunction;Frontiers in Endocrinology;2023-02-13

3. Classic endocrine disorders: implications for cardiovascular disease;Cardiovascular Endocrinology and Metabolism;2023

4. Research Progress of Hypoglycemia;Advances in Clinical Medicine;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3